Research Articles
The Nano-Revolution: How Polymer Supercarriers Are Turbocharging Cancer Immunotherapy
Exploring how multifunctional polymeric nanoparticles are revolutionizing cancer immunotherapy through advanced RNA delivery systems.
The Invisible Saboteur: How Oxidative Stress Hijacks a Cellular Master Regulator
Discover how oxidative stress hijacks the cellular regulator Pin1 through lipid electrophiles, contributing to diseases like cancer and Alzheimer's.
The Molecular Architects: How a Tiny Ring Structure is Forging Smarter Cancer Weapons
Exploring how pyrido[2,3-d]pyrimidines are being engineered as precision anticancer agents through medicinal chemistry approaches.
The Silent Revolution: How Polymer-Drug Conjugates Are Rewriting Medicine's Playbook
Exploring how polymer-drug conjugates are transforming medicine by targeting novel molecular pathways with precision drug delivery.
The Hidden Current: Decoding Pollution in Oil Industry Water Samples
Exploring the invisible crisis of contaminated water in oil industry operations, detection methods, and emerging solutions.
The Click Chemistry Revolution: Forging New Cancer Warriors from Molecular Legos
Exploring the revolutionary click chemistry approach to create potent triazole-tethered isatin conjugates for cancer treatment and beyond.
Awakening the Cell's Guardian: How a Novel PP2A Agonist Takes on Notorious KRAS-Driven Cancers
Discover how SMAPs (Small Molecule Activators of PP2A) can disarm KRAS by awakening the dormant tumor suppressor PP2A in KRAS-driven cancers.
The Shape-Shifters Within: How Molecular Contortions Are Revolutionizing Cancer Drug Design
Exploring how molecular conformation dynamics are transforming cancer drug design, with focus on M1 aminopeptidase inhibitors.
The DNA Guardian's Blueprint: How p53's Tetrameric Structure Shields Against Cancer
Exploring how p53's tetrameric structure binds DNA to regulate genes critical for cancer prevention, with recent structural breakthroughs and therapeutic implications.
Unlocking New Hope: How Elacestrant Revolutionizes Breast Cancer Treatment
Discover how elacestrant, the first oral SERD approved for ER-positive, HER2-negative breast cancer with ESR1 mutations, is transforming treatment paradigms.